Tunable rare-earth fcu-metal-organic frameworks
US-10253048-B2 · Apr 9, 2019 · US
US10752643B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10752643-B2 |
| Application number | US-201916280504-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 20, 2019 |
| Priority date | Sep 5, 2013 |
| Publication date | Aug 25, 2020 |
| Grant date | Aug 25, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments of the present disclosure describe compositions comprising a molecular building block (MBB) having the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 6 N 4 C—) 6 ] or [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ], wherein RE is a rare earth metal ion. Embodiments of the present disclosure further describe methods of making a metal-organic framework (MOF) composition comprising contacting one or more molecular building blocks (MBBs) with one or more bidentate ligands, wherein the MBBs have the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 6 N 4 C—) 6 ] or [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ], wherein RE is a rare earth metal ion.
Opening claim text (preview).
What is claimed is: 1. A composition, comprising: a molecular building block (MBB) having the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ], wherein RE is a rare earth metal ion. 2. The composition of claim 1 , wherein the rare earth metal ion is selected from cerium, dysprosium, erbium, europium, gadolinium, holmium, lanthanum, lutetium, neodymium, praseodymium, promethium, samarium, scandium, terbium, thulium, ytterbium, yttrium, and combinations thereof. 3. The composition of claim 1 , further comprising a bidentate ligand. 4. The composition of claim 3 , wherein the bidentate ligand includes one or more of carboxylates, trizolates, tetrazolates, pyrazolates, and fluoros. 5. The composition of claim 4 , wherein the carboxylates are dicarboxylates. 6. The composition of claim 4 , wherein the trizolates are ditrizolates. 7. The composition of claim 4 , wherein the tetrazolates are ditetrazolates. 8. The composition of claim 4 , wherein the pyrazolates are dipyrazolates. 9. The composition of claim 3 , wherein the bidentate ligand is 2-fluoro-4-(1H-tetrazol-5-yl)benzoate (FTZB), 4-(1H-tetrazol-5-yl)benzoate (TZB), 3-fluoro-4′-(2H-tetrazol-5-yl)biphenyl-4-carboxylate (FTZBP), 3-fluorobiphenyl-4,4′-dicarboxylate (FBPDC), or 3,3′-difluorobiphenyl-4,4′-dicarboxylate (DFBPDC). 10. A method of making a metal-organic framework (MOF) composition, comprising: contacting one or more molecular building blocks (MBBs) with one or more bidentate ligands, wherein the MBBs have the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ], wherein RE is a rare earth metal ion. 11. The method of claim 10 , wherein the rare earth metal ion is selected from cerium, dysprosium, erbium, europium, gadolinium, holmium, lanthanum, lutetium, neodymium, praseodymium, promethium, samarium, scandium, terbium, thulium, ytterbium, yttrium, and combinations thereof.
Coordination polymers, e.g. metal-organic frameworks [MOF] (preparation of metal complexes containing carboxylic acid moieties C07C51/418; MOF's per se C07F) · CPC title
of CO2 · CPC title
Coordination polymers, e.g. metal-organic frameworks [MOF], zeolitic imidazolate frameworks [ZIF] (preparation of metal complexes containing carboxylic acid moieties C07C51/418; MOF's per se C07F) · CPC title
Preparation of metal complexes containing carboxylic acid moieties · CPC title
Compounds containing elements of Groups 3 or 13 of the Periodic Table · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.